Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Interleukins: Pathogenesis in Non-Alcoholic Fatty Liver Disease
Metabolites
March 2024
Rafaqat S.
Open Access
Celastrus orbiculatus Thunb. extracts and celastrol alleviate NAFLD by preserving mitochondrial function through activating the FGF21/AMPK/PGC-1α pathway
Frontiers in Pharmacology
2024
Xue J.
Open Access
Integrated bioinformatics analysis reveals potential mechanisms associated with intestinal flora intervention in nonalcoholic fatty liver disease
Medicine United States
9 September 2022
Liu Y.
Open Access
ON ASSESSING RISKS OF DEVELOPING AND PROGRESSING NON-ALCOHOLIC FATTY LIVER DISEASE USING TNF-Α, IL6, AND VEGF FACTORS AND POLYMORPHISMS OF THEIR GENES
Health Risk Analysis
2022
Bulatova I.A.
Open Access
Hepatoprotective Effect of Antrodia cinnamomea Mycelium in Patients with Nonalcoholic Steatohepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial
Journal of the American College of Nutrition
2021
Chiou Y.L.
Evaluation of Polymorphisms in IL8 and IL16 Genes in Patients with Acute Coronary Syndrome
International Journal of Cardiovascular Sciences
2020
Silva L.C.A.
Open Access
Association between chemokines and nonalcoholic fatty liver disease
Journal of Clinical Hepatology
July 2019
Chu P.
Interleukin-6 gene polymorphisms and susceptibility to liver diseases: A meta-analysis
Medicine United States
2019
Wang X.
Open Access
Analysis of mulberry leaf components in the treatment of diabetes using network pharmacology
European Journal of Pharmacology
15 August 2018
Ge Q.
Gut microbiota, fatty liver disease, and hepatocellular carcinoma
Liver Research
March 2018
Chu H.
Open Access
Branched chain amino acids supplementation modulates TGF-β1/Smad signaling pathway and interleukins in CCl4-induced liver fibrosis
Fundamental and Clinical Pharmacology
October 2017
Khedr N.F.
Chicoric acid attenuate a nonalcoholic steatohepatitis by inhibiting key regulators of lipid metabolism, fibrosis, oxidation, and inflammation in mice with methionine and choline deficiency
Molecular Nutrition and Food Research
May 2017
Kim M.
Protective effect and underlying mechanism of cordycepin on non-alcoholic fatty liver in ob/ob mice
Yaoxue Xuebao
12 January 2017
Zhong L.P.
Cytokines Genotype-Phenotype Correlation in Nonalcoholic Steatohepatitis
Oxidative Medicine and Cellular Longevity
2017
Bocsan I.C.
Open Access
Caspase 3, 6, 8, and 9 Gene Expression in Peripheral Blood Leukocytes and Plasma Concentrations of IL-6 and TNF-α in Carriers of Different Polymorphic Marker -174G>C Genotypes of IL6 Gene Associated with the Risk of Nonalcoholic Steatohepatitis
Bulletin of Experimental Biology and Medicine
1 January 2017
Kurbatova I.V.
MicroRNA-26a–interleukin (IL)-6–IL-17 axis regulates the development of non-alcoholic fatty liver disease in a murine model
Clinical and Experimental Immunology
1 January 2017
He Q.
All Open Access, Green
Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico
World Journal of Gastroenterology
7 November 2015
Ramos-Lopez O.
Open Access
Genetic polymorphisms and oxidative stress in non-alcoholic steatohepatitis (NASH): A mini review
Clinics and Research in Hepatology and Gastroenterology
1 September 2015
Oliveira C.P.